Patent Number: 7,968,688

Title: Antibodies that bind to the C35 polypeptide

Abstract: The present invention relates to a novel human gene that is differentially expressed in human carcinoma. More specifically, the present invention relates to a polynucleotide encoding a novel human polypeptide named C35 that is overexpressed in human breast and bladder carcinoma. This invention also relates to C35 polypeptide, in particular C35 peptide epitopes and C35 peptide epitope analogs, as well as vectors, host cells, antibodies directed to C35 polypeptides, and the recombinant methods for producing the same. The present invention further relates to diagnostic methods for detecting carcinomas, including human breast carcinomas. The present invention further relates to the formulation and use of the C35 gene and polypeptides, in particular C35 peptide epitopes and C35 peptide epitope analogs, in immunogenic compositions or vaccines, to induce antibody or cell-mediated immunity against target cells, such as tumor cells, that express the C35 gene. The invention further relates to screening methods for identifying agonists and antagonists of C35 activity.

Inventors: Zauderer; Maurice (Pittsford, NY), Evans; Elizabeth E. (Bloomfield, NY)

Assignee: University of Rochester

International Classification: C12P 21/08 (20060101); C07K 16/00 (20060101); C12P 21/04 (20060101); A61K 39/395 (20060101)

Expiration Date: 2019-06-28 0:00:00